Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 3

Status

Completed 6Terminated 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 4Breast 4Tumor-Agnostic 3Other hematologic neoplasm 3Sarcoma 2Plasma cell 1Other solid neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Rectal Neoplasms 2Liver Neoplasms 1Gastrointestinal Stromal Tumors 1Esophagogastric Cancer 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × STA 9090 × Gastrointestinal × Clear all
NCT01167114 2023-11-02

STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer

Massachusetts General Hospital

Phase 2 Completed
28 enrolled
Gastrointestinal

Esophagogastric Cancer

NCT02389751 2019-07-24

Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
3 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01665937 2018-04-25

STA-9090 in Patients With Advanced Hepatocellular Cancer

Massachusetts General Hospital

Phase 1 Completed
16 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01039519 2016-03-10

A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)

Synta Pharmaceuticals Corp.

Phase 2 Completed
27 enrolled 22 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01554969 2016-02-22

Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer

Emory University

Phase 1 Completed
16 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01111838 2015-11-20

Clinical and Translational Study of STA-9090

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
20 enrolled 6 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡